The Data Chronicles | Behind the curtain | FDA and privacy considerations in clinical trial recruitment

Welcome to Hogan Lovells’ The Data Chronicles, brought to you by the firm’s global Privacy and Cybersecurity practice. This multimedia series is dedicated to the ever-changing legal and regulatory developments in the world of data, privacy, and cybersecurity.

Explore the challenges of clinical trial recruitment within the life sciences sector in this episode of The Data Chronicles. Successful clinical trial recruitment is critically important to any research sponsor, including pharmaceutical and medical device companies and this poses a number of complex FDA and privacy considerations. Host Scott Loughlin is joined by fellow Hogan Lovells lawyers Robert Church, a partner in the FDA practice, and Melissa Levine, counsel in our Privacy and Cybersecurity practice. Together, they discuss how organizations can navigate the regulatory landscape and address the unique hurdles that arise in attracting and enrolling suitable data subjects for clinical studies.

Contacts
Scott Loughlin
Partner
Washington, D.C.
Robert Church
Partner
Los Angeles
Melissa Levine
Counsel
Washington, D.C.

 

This website is operated by Hogan Lovells International LLP, whose registered office is at Atlantic House, Holborn Viaduct, London, EC1A 2FG. For further details of Hogan Lovells International LLP and the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses ("Hogan Lovells"), please see our Legal Notices page. © 2024 Hogan Lovells.

Attorney advertising. Prior results do not guarantee a similar outcome.